Carbamazepine reduces short-interval interhemispheric inhibition in healthy humans |
| |
Authors: | Martin Sommer Elena Gileles Kathrin Knappmeyer Holger Rothkegel Rafael Polania Walter Paulus |
| |
Affiliation: | 1. Department of Clinical Neurophysiology, University of Göttingen, Germany;2. Paracelsus-Elena-Klinik, Kassel, Germany;3. Department of Pediatrics, St. Marienhospital, Vechta, Germany;4. Department of Neurology, University Hospital of Schleswig-Holstein Campus Kiel, Germany |
| |
Abstract: | ObjectiveWe sought to elucidate the influence of centrally active drugs on interhemispheric inhibition (IHI) between primary motor cortices in healthy humans.MethodsWe therefore studied IHI before and 2 h after intake of a single oral dose of carbamazepine, dextrometorphane, lorazepam, or placebo and compared it with the well known results for short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF). Drugs were tested in separate sessions and in random order.ResultsWhile SICI and ICF were not altered by carbamazepine, IHI was reduced at the interstimulus interval of 8 ms. Dextrometorphane tended to enhance SICI and to reduce ICF and had no effect on IHI. Lorazepam reduced ICF as expected and enhanced IHI at the long intervals of 50 and 80 ms. A moderate trend for interhemispheric facilitation was inconsistently observed at the interval 2 ms and blocked by carbamazepine. In addition, carbamazepine increased the motor threshold.ConclusionsWe conclude that circuits mediating short interstimulus intervals of IHI are susceptible to sodium channel blockade.SignificanceThe results increase our knowledge of interhemispheric transmission. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|